#PRESSRELEASE Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate). Details at: bit.ly/3Kn5nn5 #ClarusThera #CRXT $CRXT #testosterone #menshealth

#PRESSRELEASE Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at the 2022 American Urological Association Annual Meeting. Details at: bit.ly/3P0TBlQ #ClarusThera #CRXT $CRXT #AUA2022 #testosterone #menshealth

#PRESSRELEASE Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering CLAR-121 (Testosterone + Anastrozole) for Treatment of Androgen-Mediated Autoimmune Inflammatory Mastitis. Details at: bit.ly/394xbzI #ClarusThera #CRXT $CRXT

#PRESSRELEASE Clarus Therapeutics to Report First Quarter 2022 Financial and Operating Results. Details at: bit.ly/3l1RMY8 #ClarusThera #CRXT #earnings $CRXT

We are thrilled to be live at #AUA2022 this weekend in beautiful #NewOrleans! Stop by and see our team at booth #1507! #ClarusThera #CRXT #menshealth

#PRESSRELEASE Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results. Details at: bit.ly/3wiZCD3 #ClarusThera #CRXT $CRXT #earnings #menshealth

#PRESSRELEASE Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate). Details at: bit.ly/3ln3yMY #ClarusThera #CRXT $CRXT #menshealth #patents

Today we remember and honor the brave men and women who served and sacrificed for our country. Thank you to the heroes who gave their lives for our freedom. #MemorialDay2022

We are revolutionizing men's health by focusing on the hypogonadal man. #ClarusThera #menshealth #MensHealthMonth #testosterone

#PRESSRELEASE Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting. Details at: bit.ly/3H5svqj #ClarusThera #ENDO2022 #MensHealth #testosterone #CRXT $CRXT

We are thrilled to be in Atlanta for ENDO 2022! #ClarusThera #ENDO2022 #CRXT #menshealth

We are live at ENDO 2022 in Atlanta! Visit us at booth #1731. #ClarusThera #ENDO2022 #menshealth #menshealthawareness #menshealthweek #menshealthmonth #testosterone $CRXT

#ENDO2022 has been outstanding! A special thanks to presenter Ronald Swerdloff, MD! #ClarusThera #CRXT $CRXT #menshealth #menshealthweek #menshealthmonth #menshealthawareness #testosterone

June 19 (Juneteenth), 1865 marks the day when federal troops arrived in Galveston, Texas to free enslaved African Americans months after the Civil War ended. We are honored to observe this #freedomday. #juneteenth #juneteenth2022 #ClarusThera

June is Men's Health Month and the perfect time to ask your healthcare provider about #hypogonadism. #ClarusThera #menshealthmonth #menshealthmonth #testosteronereplacementtherapy #CRXT

Today is a great day to schedule your annual checkup if you haven't done so already. #Menshealthmonth #menshealth #hypogonadism #testosterone #ClarusThera #CRXT

A safe and enjoyable Fourth of July to you! #fourthofjuly #fourthofjuly2022 #ClarusThera #CRXT

Introducing our new Clinical Sales Specialists – Andrew, Luke, Mylene, Alex, and Troy! Welcome to Team Clarus! We are thrilled to have you! #ClarusThera #menshealth #testosterone #CRXT $CRXT

#PRESSRELEASE: Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO(R) (testosterone undecanoate). Read more at: bit.ly/3vn8aIb. #ClarusThera $CRXT #CRXT #testosterone #menshealth

#PRESSRELEASE Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction. Read more at: bit.ly/3duGsTO #ClarusThera #CRXT $CRXT #earnings